Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (80,107)	$ 12,310
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	24,236	26,855
Equity-based compensation expense	14,050	18,006
Bad debt expense	4,903	1,256
Deferred income tax expense (benefit)	51,799	(41)
Fair value adjustments to contingent consideration	(379)	1,303
Settlement charge	55,000
Impairment charge - leased assets		6,248
Loss on sale or disposition of assets, net	386	1,314
Non-cash lease benefit	(2,242)	(1,539)
Non-cash loss on lease termination		1,175
Non-cash debt charges	644	644
Gain on reduction in tax receivable agreement liability	(24,917)
Other, net	(73)	70
Changes in operating assets and liabilities	(23,675)	(6,215)
Net cash provided by operating activities	19,625	61,386
Cash flows from investing activities:
Purchases of property, equipment and capitalization of software	(4,249)	(7,950)
Other	679	(1,915)
Net cash used in investing activities	(3,570)	(9,865)
Cash flows from financing activities:
Payments on debt	(3,450)	(3,450)
Distributions paid to non-controlling unitholders	(8,667)	(10,923)
Dividends and dividend equivalents paid to Class A common stockholders	(13,492)	(13,969)
Payments related to tax withholding for share-based compensation	(4,014)	(6,356)
Common shares repurchased	(3,408)	(23,795)
Payment of contingent consideration	(360)	(120)
Net cash used in financing activities	(33,391)	(58,613)
Effect of exchange rate changes on cash	21	(2,009)
Net decrease in cash, cash equivalents and restricted cash	(17,315)	(9,101)
Cash, cash equivalents and restricted cash, beginning of period	138,128	158,399
Cash, cash equivalents and restricted cash, end of period	$ 120,813	$ 149,298